In the News

SGLT-2 inhibitors reduce cardiac events, mortality compared to DPP-4 inhibitors

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors were associated with lower risk of cardiovascular events compared to dipeptidyl peptidase-4 (DPP-4) inhibitors but higher risk of genital infections and diabetic ketoacidosis, a retrospective study found.

Metformin during pregnancy not associated with adiposity in children

A follow-up study of a randomized trial of women with type 2 diabetes during pregnancy found that scores for body mass index were similar up to age 24 months in children who were and were not exposed to metformin in utero.

Vitamin D may reduce risk of progression to diabetes from prediabetes

In adults with prediabetes, high-dose vitamin D was associated with a 12% to 15% reduced risk for diabetes compared with placebo, a systematic review and meta-analysis found, but an editorial cautioned about the uncertain risk of adverse effects.

MKSAP quiz: Diabetic ketoacidosis

This month's quiz asks readers to choose a treatment for a patient with type 1 diabetes who uses an insulin pump and is being evaluated for diabetic ketoacidosis.

Spotlight on diabetes incidence in the pandemic

Two studies tried to determine whether COVID-19 infection leads to a subsequent increase in the risk of developing diabetes, while another highlighted how type 2 diabetes has risen among youth since the start of the pandemic.

FDA clears marketing of mobile app for automated insulin dosing in type 1 diabetes

The prescription-only mobile application is intended for use with compatible devices for automated insulin dosing to help manage type 1 diabetes in persons ages 6 years and older.